Patients who already qualify for GLP-1 therapy and would like additional support Individuals with suboptimal B12 levels or risk of deficiency Those who prefer combining metabolic and micronutrient therapy Patients fully committed to close medical oversight and follow-up However, its not recommended if you have contraindications to GLP-1 agents, are pregnant, breastfeeding, have uncontrolled GI disease, or cannot adhere to monitoring and follow-up
Understanding BUD matters
Deficiency, defined as serum 25-hydroxyvitamin D below 30 ng/mL, has been associated with both telogen effluvium and alopecia areata
Mean baseline body weight was approximately 112.7 kg
Thousands of Elmiron Lawsuits have been filed against Janssen Pharmaceuticals, the manufacturer, alleging that the company failed to warn patients about the potential risks
Always work with your healthcare provider regarding your medication, nutrition, and any health concerns